Home › Companies › Elevance Health, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Elevance Health, Inc.’s Form 8-K, filed 2026-05-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Elevance Health, Inc. in the interactive database Compare manager voting policies
These tallies are Elevance Health, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Gail K. Boudreaux | 177,978,713 | 1,714,229 | 110,827 | -- | 14,637,570 | Majority: yes |
| Elect Director: Robert L. Dixon, Jr. | 174,098,489 | 5,590,793 | 114,487 | -- | 14,637,570 | Majority: yes |
| Elect Director: Deanna D. Strable | 175,331,822 | 4,360,980 | 110,967 | -- | 14,637,570 | Majority: yes |
| Proposal 2: Advisory vote on the Company's executive compensation . | 172,363,616 | 7,240,619 | 199,534 | -- | 14,637,570 | Majority: yes |
| Proposal 3: Ratification of the appointment of Ernst & Young LLP . | 175,183,332 | 19,141,697 | 116,310 | -- | -- | Majority: yes |
| Proposal 4: Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups. | 15,587,160 | 162,924,290 | 1,292,319 | -- | 14,637,570 | Majority: no |
Source: Elevance Health, Inc., Form 8-K, filed with the SEC on 2026-05-13 — read the filing on EDGAR.
Each item below shows how the 1,165 asset managers that disclosed a Elevance Health, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Elevance Health, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-13.
Combines 39 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 172,363,616 for, 7,240,619 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 79% for, 3% against (83% of the company cast a for/against vote).
The 1,145 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,053,578 | 89 | 2 | 0 | For |
| BlackRock | 17,125,644 | 6,675 | 0 | 0 | For |
| Wellington | 7,796,686 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,343,230 | 5,217 | 0 | 0 | For |
| Invesco | 7,165,781 | 0 | 0 | 0 | For |
| Fidelity | 6,614,335 | 0 | 0 | 0 | For |
| State Street | 6,506,918 | 5,722 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,203,975 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES L P | 4,336,125 | 0 | 0 | 0 | For |
| Artisan | 4,233,037 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 3,754,436 | 0 | 0 | 0 | For |
| Charles Schwab | 3,508,394 | 0 | 0 | 0 | For |
| Sanders Capital, LLC | 3,111,910 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| John Hancock | 2,918,841 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,649,997 | 0 | 0 | 0 | For |
| Nuveen | 2,399,086 | 0 | 0 | 0 | For |
| Capital Group | 2,110,004 | 0 | 100 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,039,083 | 0 | 0 | 0 | For |
| Northern Trust | 1,992,325 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,734,738 | 0 | 0 | 0 | For |
| Amundi | 1,615,714 | 4,061 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| UBS | 1,487,860 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,145 asset managers. See all 1,145 in the interactive database.
Meeting held 2026-05-13.
Combines 9 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Elect Director: Gail K. Boudreaux”): 177,978,713 for, 1,714,229 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 82% for, 0.8% against (83% of the company cast a for/against vote).
The 199 asset managers below cast 99.9% of the shares they voted on this item FOR (64,411,395 for, 20,522 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,838 | 23 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,750 | 18 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,552 | 0 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Brighthouse | 512,710 | 0 | 8,055 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 199 asset managers. See all 199 in the interactive database.
Meeting held 2026-05-13.
Combines 10 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Elect Director: Robert L. Dixon, Jr.”): 174,098,489 for, 5,590,793 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 80% for, 3% against (83% of the company cast a for/against vote).
The 199 asset managers below cast 99.9% of the shares they voted on this item FOR (64,384,302 for, 47,615 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,782 | 79 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,737 | 31 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,552 | 0 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Brighthouse | 512,710 | 0 | 8,055 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 199 asset managers. See all 199 in the interactive database.
Meeting held 2026-05-13.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Elect Director: Deanna D. Strable”): 175,331,822 for, 4,360,980 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 81% for, 2% against (83% of the company cast a for/against vote).
The 197 asset managers below cast 99.9% of the shares they voted on this item FOR (64,317,231 for, 42,860 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,799 | 61 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,768 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,358 | 194 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Brighthouse | 512,243 | 467 | 8,055 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 197 asset managers. See all 197 in the interactive database.
Meeting held 2026-05-13.
Combines 8 wordings of this item as funds reported it.
9% Majority: no · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 4: Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups.”): 15,587,160 for, 162,924,290 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 7% for, 75% against (82% of the company cast a for/against vote).
The 197 asset managers below cast 0.7% of the shares they voted on this item FOR (424,795 for, 63,606,162 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 25,309 | 20,005,538 | 14 | 0 | Against |
| BlackRock | 5,293 | 7,235,332 | 0 | 0 | Against |
| Fidelity | 0 | 5,246,575 | 0 | 0 | Against |
| FIRST EAGLE FUNDS | 0 | 3,019,702 | 0 | 0 | Against |
| Invesco | 0 | 2,644,440 | 0 | 0 | Against |
| State Street | 591 | 2,450,177 | 0 | 0 | Against |
| T. Rowe Price | 0 | 2,029,476 | 0 | 0 | Against |
| HARRIS ASSOCIATES INVESTMENT TRUST | 0 | 1,987,902 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,734,521 | 0 | 0 | Against |
| MFS | 0 | 1,568,797 | 0 | 0 | Against |
| TIAA | 0 | 1,383,393 | 0 | 0 | Against |
| Capital Group | 0 | 1,057,832 | 0 | 0 | Against |
| John Hancock | 0 | 959,122 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 924,953 | 0 | 0 | Against |
| Hartford | 0 | 812,552 | 0 | 0 | Against |
| Dimensional | 0 | 790,471 | 0 | 0 | Against |
| FRANKLIN MUTUAL SERIES FUNDS | 0 | 700,704 | 0 | 0 | Against |
| First Trust | 0 | 597,911 | 0 | 0 | Against |
| GMO | 0 | 589,528 | 0 | 0 | Against |
| BNY Mellon | 0 | 584,731 | 0 | 0 | Against |
| SEQUOIA FUND INC | 0 | 532,467 | 0 | 0 | Against |
| Jackson National | 0 | 516,800 | 0 | 0 | Against |
| Nuveen | 0 | 440,529 | 0 | 0 | Against |
| Brighthouse | 0 | 418,354 | 15,149 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 341,168 | 0 | 0 | Against |
Showing the 25 largest of 197 asset managers. See all 197 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP .”): 175,183,332 for, 19,141,697 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 81% for, 9% against (89% of the company cast a for/against vote).
The 196 asset managers below cast 97% of the shares they voted on this item FOR (62,596,078 for, 1,763,912 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,178,084 | 852,776 | 1 | 0 | For |
| BlackRock | 7,239,348 | 1,277 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,737 | 31 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,358 | 194 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 45,992 | 538,739 | 0 | 0 | Against |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Brighthouse | 512,243 | 467 | 8,055 | 0 | For |
| Jackson National | 353,563 | 163,237 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 196 asset managers. See all 196 in the interactive database.
Meeting held 2026-05-13.
9% Majority: no · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 4: Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups.”): 15,587,160 for, 162,924,290 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 7% for, 75% against (82% of the company cast a for/against vote).
The 6 asset managers below cast 2% of the shares they voted on this item FOR (4,824 for, 299,054 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Advisors' Inner Circle Fund III | 0 | 107,007 | 0 | 0 | Against |
| Brighthouse | 0 | 87,262 | 0 | 0 | Against |
| GuideStone | 0 | 65,608 | 0 | 0 | Against |
| Empower | 0 | 35,930 | 0 | 0 | Against |
| AGF Investments Trust | 4,824 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 3,247 | 0 | 0 | Against |
Meeting held 2026-05-13.
Combines 2 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP .”): 175,183,332 for, 19,141,697 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 81% for, 9% against (89% of the company cast a for/against vote).
The 6 asset managers below cast 10% of the shares they voted on this item FOR (6,977 for, 65,057 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cardano Risk Management B.V. | 0 | 64,812 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 6,769 | 197 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 100 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 99 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 0 | 48 | 0 | 0 | Against |
| TEALWOOD ASSET MANAGEMENT INC | 9 | 0 | 0 | 0 | For |
Meeting held 2025-05-14 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 173,964,580 for, 15,522,459 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).
The 5 asset managers below cast 82% of the shares they voted on this item FOR (51,936 for, 11,174 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Investment Management Corp of Ontario | 44,222 | 0 | 0 | 0 | For |
| OSSIAM | 0 | 11,174 | 0 | 0 | Against |
| GLENMEDE FUND INC | 7,535 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 157 | 0 | 0 | 0 | For |
| FIRST UNITED BANK & TRUST | 22 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (71,826 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cardano Risk Management B.V. | 64,812 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 6,966 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 48 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (358 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 229 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 129 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
96% Majority: yes · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 172,363,616 for, 7,240,619 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 79% for, 3% against (83% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (358 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 229 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 129 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (234 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 229 | 0 | 0 | 0 | For |
| Ballew Advisors, Inc | 5 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Williamson Legacy Group, LLC | 99 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 9 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
9% Majority: no · of votes cast
Elevance Health, Inc.’s own tally for this item (“Proposal 4: Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups.”): 15,587,160 for, 162,924,290 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 217,162,380 outstanding shares: 7% for, 75% against (82% of the company cast a for/against vote).
The 2 asset managers below cast 92% of the shares they voted on this item FOR (99 for, 9 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Williamson Legacy Group, LLC | 99 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 0 | 9 | 0 | 0 | Against |
Ranked by the number of Elevance Health, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 217,162,380 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.23% |
| 2 | BlackRock | 7.89% |
| 3 | Wellington | 3.59% |
| 4 | T. Rowe Price | 3.38% |
| 5 | Invesco | 3.30% |
| 6 | Fidelity | 3.05% |
| 7 | State Street | 3.00% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.40% |
| 9 | HARRIS ASSOCIATES L P | 2.00% |
| 10 | Artisan | 1.95% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 9.16% | 13F |
| State Street | 4.74% | 13F |
| Wellington Management | 3.79% | 13F |
| Invesco | 2.22% | 13F |
| T. Rowe Price | 2.19% | 13F |
| BNY Mellon | 1.31% | 13F |
| Morgan Stanley | 1.16% | 13F |
| Northern Trust | 0.99% | 13F |
Percentages above are of 217,162,380 shares outstanding, as reported by Elevance Health, Inc. on its Form 10-Q dated 2026-04-15 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elevance Health, Inc.’s 10-Q dated 2026-04-15. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Elevance Health, Inc.'s shareholder meeting held 2026-05-13, in the 2025-2026 proxy season, 1,165 asset managers reported how they voted in their SEC Form N-PX filings, covering 7,408 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Elevance Health, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-13.
Elevance Health, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).